SciSparc SPRC
NASDAQ SPRC
$4.70 -0.20 (-4.18%)
As of: Sep 29, 2026 · 3:57 PM EDT

SciSparc (SPRC) Notes Payables (2020)

Updated

SciSparc's Notes Payables came in at $188,000 for Q4 2020.

Analysis

SciSparc (SPRC) Notes Payables (2020) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn
10 SciSparc 609,748.33 1.52 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2020 188,000.00
Jun 30, 2020 61,000.00
API Access

SciSparc Notes Payables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=notes-payables&ticker=SPRC&period=max&api_key=YOUR_API_KEY